BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP
237 results:

  • 1. SAKK57/16 Nab-paclitaxel and Gemcitabine in Soft Tissue Sarcoma (NAPAGE): a phase I/II trial.
    Digklia A; Kollár A; Dietrich D; Kronig MN; Britschgi C; Rordorf T; Joerger M; Krasniqi F; Metaxas Y; Colombo I; Ribi K; Rothermundt C
    Eur J Cancer; 2024 Jan; 197():113470. PubMed ID: 38096656
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Germline BRCA2 variant with low variant allele frequency detected in tumor-only comprehensive genomic profiling.
    Hayashi H; Kunimasa K; Tanishima S; Nakamura K; Ishikawa M; Kato Y; Aimono E; Kawano R; Nishihara H
    Cancer Sci; 2024 Feb; 115(2):682-686. PubMed ID: 38086530
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The oncogenic fusion protein TAZ::CAMTA1 promotes genomic instability and senescence through hypertranscription.
    Neil E; Paredes R; Pooley O; Rubin B; Kouskoff V
    Commun Biol; 2023 Nov; 6(1):1174. PubMed ID: 37980390
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pooled Safety Analysis of Single-Agent Lurbinectedin in Patients With Advanced Solid Tumours.
    Leary A; Oaknin A; Trigo JM; Moreno V; Delord JP; Boni V; Braña I; Fernández C; Kahatt C; Nieto A; Cullell-Young M; Zeaiter A; Subbiah V
    Eur J Cancer; 2023 Oct; 192():113259. PubMed ID: 37634282
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
    Pearson ADJ; Federico S; Gatz SA; Ortiz M; Lesa G; Scobie N; Gounaris I; Weiner SL; Weigel B; Unger TJ; Stewart E; Smith M; Slotkin EK; Reaman G; Pappo A; Nysom K; Norga K; McDonough J; Marshall LV; Ludwinski D; Ligas F; Karres D; Kool M; Horner TJ; Henssen A; Heenen D; Hawkins DS; Gore L; Bender JG; Galluzzo S; Fox E; de Rojas T; Davies BR; Chakrabarti J; Carmichael J; Bradford D; Blanc P; Bernardi R; Benchetrit S; Akindele K; Vassal G
    Eur J Cancer; 2023 Sep; 190():112950. PubMed ID: 37441939
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical characteristics and outcomes for children, adolescents and young adults with "CIC-fused" or "BCOR-rearranged" soft tissue sarcomas: A multi-institutional European retrospective analysis.
    Sparber-Sauer M; Corradini N; Affinita MC; Milano GM; Pierron G; Carton M; Tirode F; Pissaloux D; Alaggio R; Vokuhl C; Bisogno G; Berlanga P; Ferrari A; Orbach D
    Cancer Med; 2023 Jul; 12(13):14346-14359. PubMed ID: 37212486
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. iris and orbital myeloid sarcoma in a pediatric patient.
    Qin VL; Verkuil L; Zanganeh T; Wertheim G; Davidson SL
    J AAPOS; 2023 Jun; 27(3):157-160. PubMed ID: 37207926
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Impact of valganciclovir therapy on severe iris-Kaposi Sarcoma mortality: An open-label, parallel, randomized controlled trial.
    Volkow P; Chavez Galan L; Ramon-Luing L; Cruz-Velazquez J; Cornejo-Juarez P; Sada-Ovalle I; Perez-Padilla R; Islas-Muñoz B;
    PLoS One; 2023; 18(5):e0280209. PubMed ID: 37195970
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Germline drivers of gynecologic carcinosarcomas.
    Sia TY; Gordhandas SB; Birsoy O; Kemel Y; Maio A; Salo-Mullen E; Sheehan M; Hensley ML; Rubinstein M; Makker V; Grisham RN; O'Cearbhaill RE; Roche KL; Mueller JJ; Leitao MM; Sonoda Y; Chi DS; Abu-Rustum NR; Berger MF; Ellenson LH; Latham A; Stadler Z; Offit K; Aghajanian C; Weigelt B; Mandelker D; Liu YL
    Gynecol Oncol; 2023 Jul; 174():34-41. PubMed ID: 37149903
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Critical Review of Oncologic Medical Malpractice Claims Against Orthopaedic Surgeons.
    Davis W; Kichena S; Eckhoff MD; Childs BR; Rajani R; Wells ME; Kelly SP
    J Am Acad Orthop Surg Glob Res Rev; 2023 May; 7(5):. PubMed ID: 37141505
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Risk of obstetric and perinatal complications in women presenting with breast cancer during pregnancy and the first year postpartum in Sweden 1973-2017: A population-based matched study.
    Lundberg FE; Gkekos L; Rodriguez-Wallberg KA; Fredriksson I; Johansson ALV
    Acta Obstet Gynecol Scand; 2024 Apr; 103(4):684-694. PubMed ID: 36959086
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. What is the Value of Radiology Input During a Multidisciplinary Orthopaedic Oncology Conference?
    Komarraju A; Van Rilland EZ; Gebhardt MC; Anderson ME; Heincelman C; Wu JS
    Clin Orthop Relat Res; 2023 Oct; 481(10):2005-2013. PubMed ID: 36929904
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Relationship between PET/CT images and KRAS gene mutations in colorectal cancer in Vietnamese patients.
    Dan NV; Phuong PC; Thai PV; Nguyen NH; Loi NT; Cong BT
    Eur Rev Med Pharmacol Sci; 2023 Feb; 27(4):1480-1486. PubMed ID: 36876696
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genetic susceptibility in children, adolescents, and young adults diagnosed with soft-tissue sarcomas.
    Würtemberger J; Ripperger T; Vokuhl C; Bauer S; Teichert-von Lüttichau I; Wardelmann E; Niemeyer CM; Kratz CP; Schlegelberger B; Hettmer S
    Eur J Med Genet; 2023 May; 66(5):104718. PubMed ID: 36764384
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The BRCAness Landscape of Cancer.
    Guo M; Wang SM
    Cells; 2022 Dec; 11(23):. PubMed ID: 36497135
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Differentially Expressed Cell Cycle Genes and STAT1/3-Driven Multiple Cancer Entanglement in Psoriasis, Coupled with Other Comorbidities.
    Dorai S; Alex Anand D
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497125
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Next-generation sequencing in breast pathology: real impact on routine practice over a decade since its introduction.
    Nourieh M; Vibert R; Saint-Ghislain M; Cyrta J; Vincent-Salomon A
    Histopathology; 2023 Jan; 82(1):162-169. PubMed ID: 36482269
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Are targeted therapies or immunotherapies effective in metastatic pancreatic adenocarcinoma?
    Rémond MS; Pellat A; Brezault C; Dhooge M; Coriat R
    ESMO Open; 2022 Dec; 7(6):100638. PubMed ID: 36399952
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Avelumab Plus Talazoparib in Patients With brca1/2- or ATM-Altered Advanced Solid Tumors: Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic Trial.
    Schram AM; Colombo N; Arrowsmith E; Narayan V; Yonemori K; Scambia G; Zelnak A; Bauer TM; Jin N; Ulahannan SV; Colleoni M; Aftimos P; Donoghue MTA; Rosen E; Rudneva VA; Telli ML; Domchek SM; Galsky MD; Hoyle M; Chappey C; Stewart R; Blake-Haskins JA; Yap TA
    JAMA Oncol; 2023 Jan; 9(1):29-39. PubMed ID: 36394867
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. brca1-associated RING domain-1 (BARD1) loss and GBP1 expression enhance sensitivity to DNA damage in Ewing sarcoma.
    Maurer LM; Daley JD; Mukherjee E; Venier RE; Julian CM; Bailey NG; Jacobs MF; Kumar-Sinha C; Raphael H; Periyapatna N; Weiss K; Janeway KA; Mody R; Lucas PC; McAllister-Lucas LM; Bailey KM
    Cancer Res Commun; 2022 Apr; 2(4):220-232. PubMed ID: 36187937
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.